<DOC>
	<DOC>NCT00032942</DOC>
	<brief_summary>The purpose of this study is to evaluate lofexidine for opiate withdrawal.</brief_summary>
	<brief_title>Lofexidine for Opiate Withdrawal - 1</brief_title>
	<detailed_description>An 11 day inpatient placebo-controlled, double-blind study of 96 opiate dependent, treatment seeking individuals randomized to 2 medication groups: lofexidine and placebo to be conducted in inpatient units at 3 treatment sites.</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Lofexidine</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Male or female as least 18 yrs of age &amp; above with a current dependence on heroin, morphine or hydromorphone according to DSM4 criteria; subject ; voluntarily given consent and signed informed consent; females using appropriate birth control method. Additional criteria available during screening at the site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>opiate dependence</keyword>
</DOC>